NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant decline in short interest in August. As of August 31st, there was short interest totaling 91,719 shares, a decline of 46.6% from the August 15th total of 171,641 shares. Based on an average daily volume of 672,683 shares, the short-interest ratio is currently 0.1 days. Approximately 6.4% of the company’s stock are short sold.

Analyst Ratings Changes

Several brokerages have recently commented on NIVF. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

NewGenIvf Group Stock Down 9.6%

Shares of NASDAQ:NIVF traded down $0.09 during midday trading on Tuesday, hitting $0.84. The company’s stock had a trading volume of 177,620 shares, compared to its average volume of 283,998. NewGenIvf Group has a fifty-two week low of $0.81 and a fifty-two week high of $1,539.00. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. The stock’s 50 day simple moving average is $2.29 and its 200 day simple moving average is $9.56.

Insider Buying and Selling

In related news, Director Kong Yiu Cheung acquired 2,500,000 shares of the company’s stock in a transaction on Monday, July 27th. The shares were purchased at an average price of $1.00 per share, for a total transaction of $2,500,000.00. Following the purchase, the director owned 3,722,223 shares in the company, valued at $3,722,223. This represents a 204.55% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.